Loading...

Biotin anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_Biotin_042706
C57BL/6 mouse bone marrow cells were stained with biotinylated CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by Sav-PE (gated on total cells).
  • M1slash70_Biotin_042706
    C57BL/6 mouse bone marrow cells were stained with biotinylated CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by Sav-PE (gated on total cells).
Compare all formats
Cat # Size Price Quantity Check Availability Save
101203 50 µg $42
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101204 500 µg $105
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  2. Li S, et al. 2022. Elife. 11:. PubMed
  3. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  4. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  5. García-Hernández ML, et al. 2022. Front Immunol. 13:1026574. PubMed
  6. Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed
  7. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  8. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  9. Helfen A, et al. 2022. Neoplasia. 28:100792. PubMed
  10. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  11. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  12. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  13. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  14. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  15. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  16. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  17. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  18. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  19. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  20. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  21. Ochiai S, et al. 2014. J Immunol. 193:2504. PubMed
  22. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  23. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  24. Thierry GR, et al. 2018. J Exp Med. 215:2972. PubMed
  25. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  26. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  27. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  28. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  29. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  30. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  31. Zhou L, et al. 2021. Cell Mol Immunol. 18:698. PubMed
  32. Wang Y, et al. 2022. Front Immunol. 12:809896. PubMed
  33. Yokozeki Y, et al. 2021. BMC Musculoskelet Disord. 22:634. PubMed
  34. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  35. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  36. Elsner R, et al. 2015. PLoS Pathog. 10: 1004976. PubMed
  37. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  38. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  39. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  40. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  41. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  42. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  43. Chou H, et al. 2011. Hepatology. 53:1007. PubMed
  44. Matson CA, et al. 2020. Proc Natl Acad Sci U S A. 117:14342. PubMed
  45. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  46. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  47. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  48. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  49. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  50. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  51. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  52. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  53. Bian Y, et al. 2017. PLoS Pathog. 13:e1006384. PubMed
  54. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  55. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  56. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  57. Periasamy S, et al. 2016. PLoS Pathog. 12: 1005517. PubMed
  58. Van de Velde L, et al. 2016. Cell Rep. 17:2247-2258. PubMed
  59. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  60. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  61. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  62. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  63. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  64. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  65. Ben C, et al. 2020. J Biol Chem. 295:13965. PubMed
  66. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  67. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  68. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  69. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  70. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  71. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  72. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  73. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  74. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  75. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  76. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  77. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  78. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  79. Köchl R, et al. 2020. Elife. 9:00. PubMed
  80. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  81. Vural A, et al. 2019. J Immunol. 202:1510. PubMed
  82. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  83. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  84. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  85. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  86. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  87. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  88. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  89. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  90. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  91. Carr M, et al. 2016. Proc Natl Acad Sci U S A. 113(52):15024-15029. PubMed
  92. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  93. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  94. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  95. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  96. Au-Yeung BB, et al. 2017. J Immunol. 198:2445. PubMed
  97. Leyva‐Castillo JM et al. 2019. Immunity. 50(5):1262-1275 . PubMed
  98. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  99. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  100. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  101. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  102. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  103. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  104. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  105. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  106. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  107. Liu G, et al. 2022. Ann Transl Med. 10:693. PubMed
  108. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  109. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  110. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  111. Stofkova A, et al. 2021. Int J Mol Sci. 23:. PubMed
  112. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  113. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  114. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  115. Tsuzuki S, et al. 2015. Int Immunol. 10.1093/intimm/dxv058. PubMed
  116. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  117. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  118. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  119. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  120. Chen Z, et al. 2020. Cell Death Dis. 11:180. PubMed
  121. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  122. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  123. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  124. Wang Y, et al. 2022. Front Immunol. 13:847581. PubMed
  125. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  126. De Micheli AJ, et al. 2020. Cell Rep. 30:3583. PubMed
  127. Stofkova A, et al. 2019. Sci Rep. 2.009027778. PubMed
  128. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  129. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  130. Koide S, et al. 2022. iScience. 25:103603. PubMed
  131. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  132. Rohrbeck L, et al. 2020. Immunol Cell Biol. . PubMed
  133. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  134. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  135. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  136. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  137. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  138. Yrlid U, et al. 2019. J Leukoc Biol. 105:195. PubMed
  139. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  140. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  141. Ma C, et al. 2021. J Exp Med. :218. PubMed
  142. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  143. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  144. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  145. Teng Y, et al. 2021. Mol Ther. 29:2424. PubMed
  146. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  147. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  148. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  149. Young K, et al. 2021. Cell Stem Cell. . PubMed
  150. Frohlich J, et al. 2020. Aging (Albany NY). 12:20024. PubMed
RRID
AB_312786 (BioLegend Cat. No. 101203)
AB_312787 (BioLegend Cat. No. 101204)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV™ 395 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account